L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.
Nature communications
View this publicationNature communications
View this publicationOncoimmunology
View this publicationImmunity
View this publicationEuropean urology open science
View this publicationCell death & disease
View this publicationNature communications
View this publicationEuropean journal of cancer (Oxford, England : 1990)
View this publicationPloS one
View this publicationActa neuropathologica
View this publicationThe Journal of experimental medicine
View this publication